Since the utilization of methyltransferase-targeted therapy is becoming increasingly important in cancer treatment [51, 52], this research illustrated the potential oncogenic activity of SUV39H2 in lung adenocarcinoma and the possible target genes, which provided a deeper insight into its role in carcinogenesis. This evidence concerns the gene SUV39H2 and lung adenocarcinoma.